Why is supportive care important in myeloma?
The utility of measurable residual disease (MRD) assessment in acute myeloid leukemia (AML)
Gert J. Ossenkoppele
What are the non-drug-related aspects of patient care?
How effective are current drug treatments for patients with myeloma kidney disease?
The regulation of biosimilars